These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 17181428)

  • 41. Non-motor symptoms: identification and management.
    Muzerengi S; Contrafatto D; Chaudhuri KR
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S450-6. PubMed ID: 18267282
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discriminative power of different nonmotor signs in early Parkinson's disease. A case-control study.
    Diederich NJ; Pieri V; Hipp G; Rufra O; Blyth S; Vaillant M
    Mov Disord; 2010 May; 25(7):882-7. PubMed ID: 20198714
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonmotor manifestations in Parkinson disease.
    Bernal-Pacheco O; Limotai N; Go CL; Fernandez HH
    Neurologist; 2012 Jan; 18(1):1-16. PubMed ID: 22217609
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of early Parkinson's disease. Part 2.
    Simuni T; Lyons KE; Pahwa R; Hauser RA; Comella C; Elmer L; Weintraub D
    Eur Neurol; 2009; 61(4):206-15. PubMed ID: 19176961
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients.
    Martinez-Martin P; Schapira AH; Stocchi F; Sethi K; Odin P; MacPhee G; Brown RG; Naidu Y; Clayton L; Abe K; Tsuboi Y; MacMahon D; Barone P; Rabey M; Bonuccelli U; Forbes A; Breen K; Tluk S; Olanow CW; Thomas S; Rye D; Hand A; Williams AJ; Ondo W; Chaudhuri KR
    Mov Disord; 2007 Aug; 22(11):1623-9. PubMed ID: 17546669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
    Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Non-motor disorders in Parkinson's disease].
    Merello M
    Rev Neurol; 2008 Sep 1-15; 47(5):261-70. PubMed ID: 18780273
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of the Unified Parkinson's Disease Rating Scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease.
    Pedersen KF; Larsen JP; Aarsland D
    Parkinsonism Relat Disord; 2008; 14(3):183-6. PubMed ID: 17889589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emergence of nonmotor symptoms as the focus of research and treatment of Parkinson's disease: introduction to the special section on nonmotor dysfunctions in Parkinson's disease.
    Cronin-Golomb A
    Behav Neurosci; 2013 Apr; 127(2):135-8. PubMed ID: 23565933
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The patient with Parkinson's disease: part I-treating the motor symptoms; part II-treating the nonmotor symptoms.
    Snyder CH; Adler CH
    J Am Acad Nurse Pract; 2007 Apr; 19(4):179-97. PubMed ID: 17430539
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease.
    Martinez-Martin P; Visser M; Rodriguez-Blazquez C; Marinus J; Chaudhuri KR; van Hilten JJ; ;
    Mov Disord; 2008 Sep; 23(12):1681-8. PubMed ID: 18709672
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-motor symptoms in Parkinson's disease.
    Poewe W
    Eur J Neurol; 2008 Apr; 15 Suppl 1():14-20. PubMed ID: 18353132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Parkinson's disease risk score: moving to a premotor diagnosis.
    Winkler J; Ehret R; Büttner T; Dillmann U; Fogel W; Sabolek M; Winkelmann J; Kassubek J
    J Neurol; 2011 May; 258(Suppl 2):S311-5. PubMed ID: 21560061
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recognition and management of Parkinson's disease during the premotor (prodromal) phase.
    Truong DD; Wolters EC
    Expert Rev Neurother; 2009 Jun; 9(6):847-57. PubMed ID: 19496688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sleep-related problems of Parkinson's disease.
    Dhawan V; Healy DG; Pal S; Chaudhuri KR
    Age Ageing; 2006 May; 35(3):220-8. PubMed ID: 16638765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.
    Kulisevsky J; Pagonabarraga J
    Mov Disord; 2009 Jun; 24(8):1103-10. PubMed ID: 19353727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical usefulness of the Parkinson's disease sleep scale.
    Tse W; Liu Y; Barthlen GM; Hälbig TD; Tolgyesi SV; Gracies JM; Olanow CW; Koller WC
    Parkinsonism Relat Disord; 2005 Aug; 11(5):317-21. PubMed ID: 15882956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A questionnaire on sleep and mental disorders in Parkinson's disease (QSMDPD): development and application of a new screening tool.
    Pacchetti C; Manni R; Zangaglia R; Glorioso M; Cristina S; Terzaghi M; Ossola M; Tassorelli C; Mancini F; Nappi G
    Funct Neurol; 2004; 19(2):83-99. PubMed ID: 15274515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predicting Parkinson's disease - why, when, and how?
    Postuma RB; Montplaisir J
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S105-9. PubMed ID: 20082967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sleep disorders in Chinese patients with Parkinson's disease: validation study of a Chinese version of Parkinson's disease sleep scale.
    Wang G; Cheng Q; Zeng J; Bai L; Liu GD; Zhang Y; Tan YY; Pan J; Hong Z; Wang Y; Chen SD
    J Neurol Sci; 2008 Aug; 271(1-2):153-7. PubMed ID: 18508085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.